
 
													 
									 
															 
															Year
 
															DEALS // DEV.
 
															Country
 
															 
															Therapeutic Area
 
															Study Phase
 
															Deal Type
 
															Product Type
 
															Dosage Form
 
															Lead Product
 
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bupivacaine
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : University of California
Deal Size : Undisclosed
Deal Type : Collaboration
OncoZenge Enters into Collaboration with UCLA for Patient Engagement Study on BupiZenge
Details : The partnership focuses on a patient engagement study in managing oral mucositis pain, while exploring potential pathways toward a future IND application for BupiZenge.
Product Name : BupiZenge
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 17, 2025
Lead Product(s) : Bupivacaine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : University of California
Deal Size : Undisclosed
Deal Type : Collaboration

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Bupivacaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Baltic Sea Foundation
Deal Size : $8.3 million
Deal Type : Financing
OncoZenge Secures Approximately SEK 70 Million in Financing Ahead of spin-off and separate listing
Details : OncoZenge is developing the BUPI project under the BupiZenge ® brand , for the treatment of pain due to oral mucositis, a serious side effect of cancer treatment. BupiZenge ® has shown promising results in a phase 2 study. The capital will be used to f...
Product Name : BupiZenge
Product Type : Miscellaneous
Upfront Cash : Undisclosed
November 16, 2020
Lead Product(s) : Bupivacaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Baltic Sea Foundation
Deal Size : $8.3 million
Deal Type : Financing

 Reset All
Reset All